Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-13

Clinical Trial Update: Personalized Dual-target RTMS for Patients with Refractory Schizophrenia [NA]

View source ↗

Summary

A clinical trial update announces completion of a study evaluating personalized dual-target repetitive transcranial magnetic stimulation (RTMS) for patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Anhui Medical University | Conditions: Schizophrenia, Transcranial Magnetic Stimulation | NA | Status: COMPLETED